Press releases & publications
Novasep and Paratek enhance collaboration to manufacture omadacycline (NUZYRA®), a novel tetracycline-class antibiotic for the treatment of bacterial infections
• A collaboration based on the long-term development, scale-up and manufacture of omadacycline API
• An agreement signed during the first half of 2021, making Novasep one of Paratek’s suppliers in the global supply chain of omadacycline API
• A recognition of Novasep’s expertise in managing complex multi-site API projects, using specialized technologies
Sartorius completes acquisition of Novasep’s chromatography equipment division
• An opportunity for Novasep’s chromatography equipment division to accelerate its growth by joining an established leader in the sector
• A divestment aligned with Novasep’s core strategy, focused on CDMO services for the pharmaceutical market
Novasep: Most Promising Pharma and Life Sciences Solution Provider
Novasep has been designated by CIO Review as one of the most promising Pharma and Life Sciences solution providers in 2021!
Discover our approach explained by Jin Seok HUR, General Manager of Novasep’s Boothwyn (PA) US site, in this article.
